Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | Director | May 15, 2025 | May 16, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date May 15, 2025 · Filed May 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 77,412 |
Reported balance
After 2025-05-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-05-15 · Grant · Acquired 28,914 · Balance 77,412 F1: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2025 Filed May 16, 2025 22:10 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 28,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-009727 · form4.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,412 F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. Read SEC document |
| May 09, 2024 Filed May 10, 2024 19:52 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 11,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009852 · form4.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,498 F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. Read SEC document |
| May 12, 2023 Filed May 12, 2023 23:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 9,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-010977 · form4.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,344 F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 22:15 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 460 | $20.40 | $9,384.00 |
DisclosureSEC source: 0001062993-22-023242 · form4.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,074 Underlying: Common Stock · 460 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 20:23 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | PurchaseCommon Stock | 1,000 | $15.68 | $15,680.00 |
DisclosureSEC source: 0001062993-22-020909 · form4.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 F1 · shares: The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 13:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 337 | $27.85 | $9,385.45 |
DisclosureSEC source: 0001062993-22-019054 · form4.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,614 Underlying: Common Stock · 337 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 20:11 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | PurchaseCommon Stock | 1,000 | $31.76 | $31,760.00 |
DisclosureSEC source: 0001062993-22-016396 · form4.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 F1 · shares: The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 12:26 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 276 | $34.04 | $9,395.04 |
DisclosureSEC source: 0001062993-22-014245 · form4.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,277 Underlying: Common Stock · 276 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 02, 2022 Filed May 3, 2022 12:31 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | PurchaseCommon Stock | 2,000 | $35.00 | $70,000.00 |
DisclosureSEC source: 0001062993-22-011322 · form4.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · shares: The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020. Read SEC document |
| April 29, 2022 Filed May 3, 2022 12:31 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 4,931 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011322 · form4.xml · derivative · entry 3 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,001 Underlying: Common Stock · 4,931 shares Expires not disclosed F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| April 29, 2022 Filed May 3, 2022 12:31 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 1 | $35.49 | $35.49 |
DisclosureSEC source: 0001062993-22-011322 · form4.xml · derivative · entry 2 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,070 Underlying: Common Stock · 1 shares Expires not disclosed F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F3 · shares: Shares acquired through quarterly dividend reinvestment transaction. F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 01:08 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 217 | $43.21 | $9,376.57 |
DisclosureSEC source: 0001062993-22-006475 · form4.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,069 Underlying: Common Stock · 217 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:37 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 2 | $43.50 | $87.00 |
DisclosureSEC source: 0001062993-22-000276 · form4.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,852 Underlying: Common Stock · 2 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 13:53 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 239 | $39.21 | $9,371.19 |
DisclosureSEC source: 0001062993-21-011936 · form4.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,850 Underlying: Common Stock · 239 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 20:43 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | PurchaseCommon Stock | 1,000 | $33.33 | $33,330.00 |
DisclosureSEC source: 0001062993-21-009687 · form4.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 F1 · shares: The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:30 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 3 | $31.29 | $93.87 |
DisclosureSEC source: 0001062993-21-009073 · form4.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,611 Underlying: Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| September 13, 2021 Filed Sep 13, 2021 21:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | PurchaseCommon Stock | 1,000 | $35.00 | $35,000.00 |
DisclosureSEC source: 0000075252-21-000142 · edgar.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 F1 · shares: The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:53 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 247 | $37.93 | $9,368.71 |
DisclosureSEC source: 0000075252-21-000141 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,608 Underlying: Common Stock · 247 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| June 30, 2021 Filed Jun 30, 2021 21:23 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 7 | $42.33 | $296.31 |
DisclosureSEC source: 0000075252-21-000125 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,361 Underlying: Common Stock · 7 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 12:35 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 220 | $42.67 | $9,387.40 |
DisclosureSEC source: 0000075252-21-000118 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,354 Underlying: Common Stock · 220 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 04, 2021 Filed May 5, 2021 12:06 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | PurchaseCommon Stock | 1,000 | $35.00 | $35,000.00 |
DisclosureSEC source: 0000075252-21-000094 · edgar.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 F1 · shares: The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020. Read SEC document |
| April 29, 2021 Filed May 3, 2021 20:45 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 4,098 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000083 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,134 Underlying: Common Stock · 4,098 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 12:30 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 1 | $37.59 | $37.59 |
DisclosureSEC source: 0000075252-21-000066 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,036 Underlying: Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 01:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 266 | $34.14 | $9,081.24 |
DisclosureSEC source: 0000075252-21-000045 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,035 Underlying: Common Stock · 266 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 21:08 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | PurchaseCommon stock | 1,000 | $27.11 | $27,110.00 |
DisclosureSEC source: 0000075252-21-000009 · edgar.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 F1 · shares: The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020. F2 · price: Weighted average of the purchase price range of $26.85 through $27.37. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 13:21 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 2 | $27.05 | $54.10 |
DisclosureSEC source: 0000075252-21-000002 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,769 Underlying: Common Stock · 2 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:18 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 350 | $25.84 | $9,044.00 |
DisclosureSEC source: 0000075252-20-000149 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,767 Underlying: Common Stock · 350 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:34 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 7 | $22.56 | $157.92 |
DisclosureSEC source: 0000075252-20-000123 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,417 Underlying: Common Stock · 7 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:54 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 476 | $16.40 | $7,806.40 |
DisclosureSEC source: 0000075252-20-000114 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,410 Underlying: Common Stock · 476 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 20:36 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | PurchaseCommon stock | 10,000 | $12.96 | $129,600.00 |
DisclosureSEC source: 0000075252-20-000110 · edgar.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · price: Weighted average of the purchase price range of $12.91 through $12.97. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 21:38 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 996 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000083 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,934 Underlying: Common Stock · 996 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 11, 2020 Filed May 13, 2020 01:45 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 17,242 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000063 · edgar.xml · derivative · entry 2 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,937 Underlying: Common Stock · 17,242 shares Expires not disclosed F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 11, 2020 Filed May 13, 2020 01:45 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | PurchaseCommon stock | 10,000 | $7.29 | $72,900.00 |
DisclosureSEC source: 0000075252-20-000063 · edgar.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: Weighted average of the sale price range of $7.28 through $7.30. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:13 UTC Amendment | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 17,242 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000073 · edgar.xml · derivative · entry 2 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,937 Underlying: Common Stock · 17,242 shares Expires not disclosed F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:13 UTC Amendment | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | PurchaseCommon stock | 10,000 | $7.29 | $72,900.00 |
DisclosureSEC source: 0000075252-20-000073 · edgar.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: Weighted average of the purchase price range of $7.28 through $7.30. (footnote amended 5/13/20) Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 22:48 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 1 | $9.15 | $9.15 |
DisclosureSEC source: 0000075252-20-000037 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,695 Underlying: Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:40 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 1,087 | $7.19 | $7,815.53 |
DisclosureSEC source: 0000075252-20-000016 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,694 Underlying: Common Stock · 1,087 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 21:12 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 1 | $5.17 | $5.17 |
DisclosureSEC source: 0000075252-20-000001 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,607 Underlying: Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 22:18 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 1,234 | $6.33 | $7,811.22 |
DisclosureSEC source: 0000075252-19-000137 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,606 Underlying: Common Stock · 1,234 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 00:34 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPhantom Stock · Derivative | 15,372 | $5.76 | $88,542.72 |
DisclosureSEC source: 0000075252-19-000119 · edgar.xml · derivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,372 Underlying: Common Stock · 15,372 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.